Emma Andrus, Associate Editor

Keep up with the latest headlines in dermatology from the past week, including the AAD's vote to protect diversity, equity, and inclusion programs, a UK company's effort to democratize dermatologists’ services, and more.

ICYMI, this week we had news about AAD sessions and late-breaking research, the establishment of the very first annual National Dermatologist Day, benzene updates, and more.

The data was presented in a scientific session at the American Academy of Dermatology annual meeting.

Following Valisure’s Citizen’s Petition to the US Food and Drug Administration, we are recapping recent years of regulatory action regarding benzene and carbomers.

Acelyrin announced the positive results, of which the primary endpoint was met with high statistical significance, earlier this week.

Patients with psoriatic disease face an increased risk of cardiovascular disease. Clinicians should consider this when determining management and treatment modalities for patients with psoriasis.

We've compiled all our coverage from the biggest dermatology meeting of the year to give you a thorough recap of everything you need to know or catch up on.

Allergist immunologist Giselle Mosnaim, MD, recently spoke with Dermatology Times to discuss late-breaking phase 3 REMIX-1 and REMIX-2 data presented at the American Academy of Allergy, Asthma, and Immunology Annual Meeting.

Ahead of the next 3 months of the year, Dermatology Times wants to know what conferences and meetings you plan to attend between April and June. Share your thoughts with us by March 27.

The newly-established observation is a recognition of the commitment of dermatologists to serving the public and aims to bring awareness to the role of dermatology visits, skin checks, and more.

Frey discussed the role of various cosmeceuticals and ingredients in benefitting the skin health of patients, as well as insights into pairing OTC products with Rx.

Presented at the American Academy of Dermatology Annual Meeting, the poster was the winner of the third place poster award.

Swanson shared updates and a look ahead at what is in store for pediatric dermatology.

Presented at the American Academy of Dermatology Annual Meeting, the poster was the winner of the second place poster award.

Waibel shared pearls in laser therapy and other scar treatment modalities in her talks at the American Academy of Dermatology Annual Meeting.

Lio spoke with Dermatology Times to discuss his sessions at AAD 2024, including addressing systemic malignancies with alternative or adjunctive therapies and the importance of minimizing pain in dermatology procedures.

Burnett recently spoke with Dermatology Times to discuss the background, methods, and findings of the late-breaking INTEGUMENT-PED data, as well as its potential real-world and clinical implications.

Eichenfield discusses the late-breaking data on roflumilast cream 0.05% in the pediatric patient population and its implications.

In addition to recapping key highlights from his session, Friedman discusses what is new or upcoming in dermatology that most excites him.

Keep up with the latest headlines in dermatology from the past week, including benzene findings reported by independent laboratory Valisure, Galderma's plans for a $2.3 billion IPO on the Swiss stock exchange, and more.

Lio delves into his American Academy of Dermatology Annual Meeting session, "Dietary Triggers and Modifications of Common Dermatologic Conditions: An Evidence Based Approach."

In celebration of Women's History Month and today, which is International Women's Day, dermatologist Nicole Negbenebor, MD, discusses her journey in the dermatology space and provides advice for young women and girls aspiring to enter the medical field.

Today is International Women's Day. Dermatology Times spoke with 5 women clinicians in the field to discuss the influences and advice that brought them to where they are today.

Click here to answer our poll and let us know what disease states, topics, and research you most want to see news about throughout the conference.

Following the announcement of Valisure's findings related to benzene and benzoyl peroxide acne products, Dermatology Times spoke with David Light, co-founder and president of the laboratory behind the report, to discuss the findings, the role of stability testing requirements, and quelling fear-filled online discourse.

We've rounded up commentary from trusted dermatology experts who expressed enthusiasm and excitement for the biggest dermatology meeting of the year.

Among the many sessions to be held at the American Academy of Dermatology Annual Meeting in San Diego, California, several Dermatology Times Editorial Advisory Board members are preparing to share their knowledge and insights.

In addition to the announcement of positive data, Apogee said the trial has already exceeded its objectives ahead of schedule.

Researchers Eric Sanfilippo, BS; Leslie Castelo-Soccio MD, PhD; and Anna Yasmine Kirkorian, MD, discussed the ethical considerations and methods of removal of unwanted hair in young patients.

High levels of the chemical benzene, which has been linked to cancer, were detected in numerous consumer acne products, including from major brands such as Proactiv, Clinique, and more.